John Robinson, IMCD Business Group Director Pharmaceuticals, comments: "The acquisition of Zifroni is another important step in the globalisation of our Pharmaceutical business. Zifroni’s strong position within the innovative Israeli market and extensive portfolio in Pharmaceuticals and Personal Care, provides the perfect fit with IMCD.”
Rafi and Moshe Zifroni, Managing Directors of Zifroni say: “We are delighted to become part of the IMCD family and excited about the potential of combining our knowledge of the growing Israeli market with IMCD's global reach and strong technical formulation expertise.”
The company will continue with its present management and staff.
This website uses cookies to improve your user experience
We use cookies for a variety of purposes, such as website functionality and helping target our marketing activities. Click "accept" to accept our cookies. You can change the cookie settings by clicking "change settings".